{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-058985","form_type":"8-K/A","ticker":"BIOE","cik":"0001723059","company_name":"Bio Essence Corp","filed_at":"2026-05-19T20:01:25+00:00","discovered_at":"2026-05-19T20:02:01.501239+00:00","generated_at":"2026-05-19T20:05:56.116122+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bio Essence acquires MediFlow AI software for $3.5M in stock; closes share assignments to three individuals","bullets":["Acquired MediFlow AI (formerly AcuVital) from Zhituo Software for $3,500,000 in restricted common stock.","Board approved issuance of 7,000,000 shares at $0.50/share based on five-day trading average.","Shares assigned to three Zhituo principals: Dangwei Zhu (3.5M), Jiahui Zhang (1.75M), Xiaoquiang Cai (1.75M).","Assignments executed May 9, 2026; share issuances deemed effective May 19, 2026, closing the deal.","No prior material relationship existed between Bio Essence and Zhituo or the assignees."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-058985","json":"https://secwatch.observer/filing/0001213900-26-058985.json","markdown":"https://secwatch.observer/filing/0001213900-26-058985.md","text":"https://secwatch.observer/filing/0001213900-26-058985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1723059/000121390026058985/0001213900-26-058985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1723059/000121390026058985/ea0291489-8ka1_bioessen.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T20:05:56.116122+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2499ea5f9f49151d6b58c840d8d2ca18b29ae993","claim":"Bio Essence Corp amended Asset Purchase Agreement with Zhituo Software Co., Limited valued at shares assigned to three individual stakeholders (effective 2026-05-09).","evidence_excerpt":"On May 9, 2026, Zhituo’s three principals, Dangwei Zhu, Jiahui Zhang, and Xiaoquiang Cai, executed assignment agreements whereby each of the principals would receive a portion of the shares reserve for Zhituo pursuant to the APA.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1723059/000121390026058985/0001213900-26-058985-index.htm","confidence":0.8,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Zhituo Software Co., Limited"},{"label":"Value","value":"shares assigned to three individual stakeholders"},{"label":"Effective","value":"2026-05-09"}],"fact_type":"material_agreement"},{"claim_id":"726af87bf00bbb7c2e8314fde7b03c147da8115d","claim":"Bio Essence Corp entered into Asset Purchase Agreement with Zhituo Software Co., Limited valued at common stock valued at $3,500,000 (effective 2026-04-20).","evidence_excerpt":"On April 20, 2026, Bio Essence Corp., a California corporation (“Company”) entered into a Asset Purchase Agreement (“APA”) with Zhituo Software Co., Limited, a company incorporated under the laws of Hong Kong (“Zhituo”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1723059/000121390026058985/0001213900-26-058985-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Zhituo Software Co., Limited"},{"label":"Value","value":"common stock valued at $3,500,000"},{"label":"Effective","value":"2026-04-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}